Jie Liu

Title: Jie Liu - Innovator in Cardiac Pharmaceutical Solutions

Introduction

Jie Liu is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac conditions. With a total of 2 patents, Liu's work focuses on innovative formulations that enhance patient care.

Latest Patents

Liu's latest patents include an esmolol formulation and a ready-to-use esmolol solution. The esmolol formulation is an aqueous, sterile pharmaceutical composition suitable for parenteral administration. It is designed for the treatment of cardiac conditions and comprises methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent, and an osmotic-adjusting agent. Additionally, a method for its manufacture is disclosed. The ready-to-use esmolol solution is also an injectable, aqueous pharmaceutical composition for treating cardiac conditions, featuring similar components and a method for its manufacture in a container.

Career Highlights

Jie Liu is currently employed at Baxter International Inc., a leading global medical products company. His work at Baxter focuses on developing innovative solutions that improve patient outcomes in cardiac care.

Collaborations

Liu collaborates with esteemed colleagues, including Satish K Pejaver and George Owoo. These partnerships enhance the research and development efforts within the pharmaceutical domain.

Conclusion

Jie Liu's contributions to cardiac pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical treatments. His work continues to impact the field positively, improving the lives of patients with cardiac conditions.